{"brief_title": "An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)", "brief_summary": "The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes).", "detailed_description": "The duration of treatment is 104 weeks.", "condition": ["Diabetes Mellitus, Type 2"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["sitagliptin (MK0431)", "Comparator: glipizide"], "description": ["Sitagliptin 100 mg oral tablets of sitagliptin once daily.", "Glipizide 1 tablet (5 mg) per day. Patients could then up-titrated to a total daily dose of 4 tablets twice daily (20mg/day) based on their glycemic control."], "arm_group_label": ["Sitagliptin 100 mg", "Glipizide"], "other_name": ["MK0431", "Glipizide"], "criteria": "Inclusion Criteria: - Patients who are at least 18 years of age and not older than 78 with type 2 diabetes mellitus", "gender": "All", "minimum_age": "18 Years", "maximum_age": "78 Years", "healthy_volunteers": "No", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Sitagliptin Phosphate", "Glipizide"], "id": "NCT00094770"}